Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

AVS Partners with the Jacobs Institute to Expedite Clinical Trials for Coronary and Carotid Indications

Aug 20, 2024•about 2 years ago

Contract Type

partnership

BuffaloBiotechnologyHealth CareMedicalMedical Device

Description

Amplitude Vascular Systems (AVS) has entered into a strategic agreement with the Jacobs Institute to execute clinical studies evaluating the Pulse IVL™ System in both Coronary and Carotid vasculatures, aiming to expand clinical indications for the Pulse IVL System. This partnership combines the clinical and regulatory capabilities of the Jacobs Institute with the novel lithotripsy technology from AVS to expedite the time to market for coronary and carotid indications of the Pulse IVL System.

Company Information

Company

Amplitude Vascular Systems (AVS)

Location

Buffalo, New York, United States

About

Amplitude Vascular Systems (AVS) is a medical device company focused on safely and effectively treating severely calcified arterial disease with its Pulse Intravascular Lithotripsy platform.

Predictive Intelligence
Strategic

ML-powered predictions for Amplitude Vascular Systems (AVS)'s next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Amplitude Vascular Systems (AVS) signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.